Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

684 results
  1. NLM Digital Collections - Smaller Fleas. . .ad infinitum: Therapeutic Bacteriophage Redux 
    Publication: National Academy of Sciences (U.S.), April 1996
    ... stimulate broader renewed interest in the prospects for phage therapy, perhaps emulating their approach of getting assistance from ... the most likely targets for the application of phage therapy? We think, first of all, of organisms recalcitrant ...
  2. ... 199-208. ------ Recoveries from sta- phylococcic meningitis following bacteriophage therapy. Ibid., 507-25.—MacNeal, W. J., Spence, M. ...
  3. NLM Digital Collections - Immunity in natural infectious diseases 
    Publication: Baltimore : Williams & Wilkins Company, 1924
    ... bladder lavage. Staphylococcus infections The first attempts at bacteriophage therapy of staphylococcus infections were those published by Bruynoghe ... in, 277, 282 , bacteriophage prophy- laxis of, 298 , bacteriophage therapy of, 289 B. acridiorum, locust infection by, 76 ...
  4. ... BACTERIOPHAGE ---- Immunological aspect. See also Bacteriophage, Serology; Bacterio- phage, Therapeutic use. Herelle, F. d'. Le bacteriophage; son r61e ... 7: 65-8.— Eaton, M. B., & Bayne-Jones, S. Bacteriophage therapy; review of the principles and results of the ...
  5. ... antistaphylococcique. Rev. physiother., Par., 1938, 14: 356-63. ---- Bacteriophage: Therapeutic use. See also Micrococcosis, Treatment: Biological products; Micrococcus ...
  6. ... 698- 700.—Kessel, J. F., & Rose, E. J. Bacteriophage therapy in bacillary dysentery of the Flexner type. Ann. ... repr.—Rodkin, S. V., Zhurakhova, Ts. S.,' & Mintz, A. A. [Bacteriophage therapy in dysentery in children] Vrach. delo, 1936, 19: ...
  7. NLM Digital Collections - Development of anti-infective drug products for the pediatric population 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2021
    ... Research (CBER) (e.g., cellular and gene therapies, phage therapies), there may be additional development considerations. In such ... Research (CBER) (e.g., cellular and gene therapies, phage therapies), there may be additional development considerations. In such ...
  8. ... of 2 cases with recovery of 1 following bacteriophage therapy. J. Lab. Clin. M., 1931, 17: 28-39. ... Treatment. See also Cholera, Anti-serum; Cholera vibrio, Bacteriophage: Therapeutic use. D'Almeida Azevedo, L. *A cholera-morbus; ...
  9. NLM Digital Collections - Antibiotics : FDA has encouraged development, but needs to clarify the role of draft guidance ... 
    Publication: Washington, D.C. : U.S. Government Accountability Office, January 2017
    ... are three types of nontraditional therapies under development—phage therapy, probiotics, and fecal microbiota. • Lytic bacteriophage (phage) therapy involves the use of viruses to destroy the ...
  10. ... time to re-evaluate the possible application of bacteriophage therapy in the light of current knowledge. This did ... in purified form. Probably the main disadvantage of phage therapy is the antigenicity of the phage antigens, so ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last